Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer InstituteDaniel Herranz Benito, PharmD, PhD, resident researcher at Rutgers Cancer Institute of New Jersey, has received a five-year, $600,000 award from the Leukemia and Lymphoma Society (LLS) to support ongoing research efforts in T-cell acute lymphoblastic leukemia (T-ALL).